Vividion Therapeutics
Maurice A. Marsini currently holds the position of Vice President and Head of CMC at Vividion Therapeutics, Inc. since June 2023. Prior to this role, Marsini served at Gossamer Bio from October 2018 to May 2023, where responsibilities included leading the process chemistry team and managing drug substance deliveries for key oncology projects. Marsini's career also includes roles at Receptos, a subsidiary of Celgene, and Boehringer Ingelheim, where significant contributions were made in the development and manufacturing of APIs and complex drug candidates. Marsini's educational background includes a Ph.D. in Organic Chemistry from UC Santa Barbara and a B.S. in Chemistry from Villanova University.
This person is not in any teams
Vividion Therapeutics
2 followers
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets.